Cargando…

Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration

AIMS: The estimated effect of sodium oxybate (SMO) in the treatment of alcohol dependence is heterogeneous. Population severity and treatment duration have been identified as potential effect modifiers. Population severity distinguishes heavy drinking patients with <14 days of abstinence before t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiraud, Julien, Addolorato, Giovanni, Aubin, Henri-Jean, Bachelot, Sylvie, Batel, Philippe, de Bejczy, Andrea, Benyamina, Amine, Caputo, Fabio, Couderc, Monique, Dematteis, Maurice, Goudriaan, Anna E, Gual, Antoni, Lecoustey, Sylvie, Lesch, Otto-Michael, Maremmani, Icro, Nutt, David J, Paille, François, Perney, Pascal, Rehm, Jürgen, Rolland, Benjamin, Scherrer, Bruno, Simon, Nicolas, Söderpalm, Bo, Somaini, Lorenzo, Sommer, Wolfgang H, Spanagel, Rainer, Walter, Henriette, van den Brink, Wim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008102/ https://www.ncbi.nlm.nih.gov/pubmed/36617267 http://dx.doi.org/10.1093/alcalc/agac070

Ejemplares similares

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial
por: Guiraud, Julien, et al.
Publicado: (2022)

Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta‐regression analysis to develop an enrichment strategy
por: Scherrer, Bruno, et al.
Publicado: (2021)

Sodium Oxybate: a Substitute for Alcohol?
por: Gual, A., et al.
Publicado: (2022)

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder
por: Caputo, Fabio, et al.
Publicado: (2016)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

Sleep, Narcolepsy, and Sodium Oxybate
por: Mamelak, Mortimer
Publicado: (2022)

Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey
por: Rolland, Benjamin, et al.
Publicado: (2014)

Role of Patient Sex in Early Recovery from Alcohol-Related Cognitive Impairment: Women Penalized
por: Luquiens, Amandine, et al.
Publicado: (2019)

Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
por: Sarkanen, Tomi, et al.
Publicado: (2014)

Burden and Help-Seeking Behaviors Linked to Problem Gambling and Gaming: Observational Quantitative and Qualitative Analysis
por: Luquiens, Amandine, et al.
Publicado: (2021)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Sodium oxybate—a new horizon for symptomatic treatment of RBD?
por: Stefani, Ambra, et al.
Publicado: (2023)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Off-label Sodium Oxybate in Childhood Narcolepsy: A Comprehensive Report
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union
por: Iranzo, Alex, et al.
Publicado: (2020)

Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment
por: Morse, Anne Marie, et al.
Publicado: (2023)

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
por: Schneider, Logan D, et al.
Publicado: (2023)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Long-term Effect of Sodium Oxybate (Xyrem®) in Spasmodic Dysphonia with Vocal Tremor
por: Simonyan, Kristina, et al.
Publicado: (2013)

A Case of Off-label Sodium Oxybate in an 11-Year-Old with Narcolepsy
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder
por: During, Emmanuel H, et al.
Publicado: (2023)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Alcoholism Risk Reduction in France: A Modernised Approach Related to Alcohol Misuse Disorders
por: Brousse, Georges, et al.
Publicado: (2014)

Addendum: Brousse, G.; et al. Alcohol Risk Reduction in France: A Modernised Approach Related to Alcohol Misuse Disorders. Int. J. Environ. Res. Public Health 2014, 11, 11664-11675
por: Brousse, Georges, et al.
Publicado: (2015)

Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug-Resistant Lance–Adams Syndrome
por: Riboldi, Giulietta M., et al.
Publicado: (2019)

Sodium Oxybate: A Cause of Extreme Involuntary Weight Loss in a Young Lady
por: Noujaim, Michael G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pn5rtr28a1j5abrdjp4cr1vaa0